A

Live / Applied — First extension granted (statement of use) (as of 22 Apr 2025)

What this means for you

Not registered yet, but its 04 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97920385
Mark type
Design + words
Filed
04 May 2023
Published for opposition
27 Aug 2024
Attorney of record
Karen Won

Goods and services

  • Class 001 — Chemicals: Lipids used in the manufacture of cosmetics, beverages, food products and food supplements, lipid nanoparticles used in the manufacture of cosmetics, beverages, food products, and food supplements, lipid formulations used in the manufacture of cosmetics, beverages, food products, and food supplements; nucleic acids, namely, messenger RNA, for scientific purposes, research laboratory use
  • Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, drug delivery agents in the nature of lipid nanoparticle carriers that facilitate delivery of pharmaceutical preparations and nucleic acid therapeutics as pharmaceutical preparations; pharmaceutical preparations comprised of nucleic acids, namely, messenger RNA and lipid nanoparticles for treating cancer, genetic disorders, infectious diseases, cardiovascular diseases, liver diseases, autoimmune disorders, neurological disorders, metabolic disorders; pharmaceutical preparations, namely, vaccines for human use for treating cancer, infectious diseases, cardiovascular diseases, liver diseases, autoimmune disorders, neurological disorders, metabolic disorders, genetic disorders, allergy; pharmaceutical preparations for gene silencing, for gene editing, for antibody therapeutics, for protein replacement therapeutics, and for nucleic acid therapeutics, for treating cancer, genetic disorders, infectious diseases, cardiovascular diseases, liver diseases, autoimmune disorders, neurological disorders, metabolic disorders
  • Class 042 — Scientific and technological services: Research, development, and evaluation services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, namely, messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology; synthetic chemistry services, namely, design, synthesis, analysis, evaluation, and biophysical characterization of lipids, lipid formulations, and lipid nanoparticles; preclinical study services, namely, conducting scientific feasibility studies, namely, pharmacodynamic and pharmacokinetic studies, scientific feasibility studies as to the human safety and tolerability studies regarding clinical pathology and histopathology, immune response characterization studies, and bioanalytical services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, namely, messenger RNA, drug delivery agents, and nucleic acid therapeutics; scientific clinical research services, in the fields of chemical molecular analysis, pharmaceutical product optimization, and conducting clinical trial services for others in the field of pharmaceuticals; research and development of new formulation products for others, namely, vaccines and nucleic acid therapeutics; research and development for others in the fields of new pharmaceuticals, medical therapies, vaccines, gene therapies, drug delivery agents, and nucleic acid therapeutics for others; project management services for scientific research and development programs in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, namely, messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology; consultancy services in the fields of scientific research and development of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, namely, messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology
  • Class 045 — Legal and security services: Regulatory compliance consultancy services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid nanoparticles, nucleic acid, namely, messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology

Owner

Prosecution history

  • 24 Jan 2026 — ASSIGNED TO EXAMINER
  • 17 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
  • 22 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 22 Apr 2025 — SOU EXTENSION 1 GRANTED
  • 22 Apr 2025 — SOU EXTENSION 1 FILED
  • 22 Apr 2025 — SOU TEAS EXTENSION RECEIVED
  • 17 Dec 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 17 Dec 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 17 Dec 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 17 Dec 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 17 Dec 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 18 Oct 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 18 Oct 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 18 Oct 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 22 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT

View this trademark record on Marksy